LAUSR

Key Points Question Can an electronic patient-reported outcome (ePRO) model improve outcome in cancer immunotherapy compared with a traditional model? Findings In this randomized clinical trial of 278 patients from 28 Chinese hospitals comparing ePRO and traditional follow-up models, the intervention group showed a reduced incidence of serious immune-related adverse events, fewer emergency department visits, a lower rate of treatment discontinuation, a higher quality of life, and less time needed to implement the model. Meaning These findings suggest that the ePRO follow-up model is efficient and may provide reliable information and management recommendations in patients receiving immunotherapy for cancer.